Lakewood-Amedex Biotherapeutics (LABT) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Redhill Biopharma is the larger company by market cap ($2.5 million vs $2.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LABT | RDHL |
|---|---|---|
| Share price | $0.2449 | $0.281 |
| Market cap | $2.19M | $2.50M |
| 1-day change | +15.03% | -13.08% |
| Forward P/E | — | 9.37 |
| EPS (TTM) | $-5.57 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $8.04M |
| Revenue growth (YoY) | — | +23.17% |
| Net income (latest FY) | — | $-8.27M |
| Gross margin | — | 60.31% |
| Operating margin | — | -181.69% |
| Net margin | — | -102.80% |
| 52-week high | $98.20 | $1.60 |
| 52-week low | $0.17 | $0.281 |
| Distance from 52-week high | -99.75% | -82.44% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +4799.96% | — |
| Average volume | 16.14M | 2.08M |
| Shares outstanding | 8.95M | 8.89M |
| Employees | 5 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
LABT vs RDHL FAQ
Which is bigger, Lakewood-Amedex Biotherapeutics or Redhill Biopharma?
Redhill Biopharma (RDHL) is larger, with a market capitalization of $2.50M compared with $2.19M for Lakewood-Amedex Biotherapeutics (LABT).
Are Lakewood-Amedex Biotherapeutics and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.